Corey Ribotsky and Research at the LLS

top_leukemia_logoAt the Leukemia and Lymphoma Society, founded in 1949, the mandate is to fund research and education with the ultimate goal of finding the cure for the various blood cancers. Supporting this worthy cause is Corey Ribotsky and the NIR Group, where he holds the position of managing member.

Supporting research which will eventually lead to the cures for lymphoma, Hodgkin’s disease, Lymphoma and melanoma is ultimately the best way to support the families with these devastating blood diseases. LLS hopes to make this dream a reality through funding research grants to investigators in research centers throughout the world.

The Leukemia and Lymphoma Society also sponsors continuing education for professionals in forums such as conferences, webcasts, meetings and teleconferences. These gatherings and discussions are geared towards a large variety of healthcare workers including physicians and researchers.

Corey Ribotsky is excited that he, along with the NIR Group are part of this important organization.

Corey Ribotsky in Support of the Leukemia and Lymphoma Society

researchThe NIR Group of Roslyn, New York, with Corey Ribotsky at the helm, is involved in many philanthropic endeavors as their way of supporting and giving back to the community. Among those organizations is the Leukemia and Lymphoma Society.

At the Leukemia and Lymphoma Society the goal is to fund research so that the cure for the various types of blood cancers can be found. In addition the Society supports education, patient services and improvement of the quality of life of patients as well as their families.

The Leukemia and Lymphoma Society was created in 1949, and since that time the organization has invested over $360 million into research into the blood cancers including leukemia, Hodgkin’s disease, lymphoma as melanoma.